methylprednisolone has been researched along with hydroxychloroquine in 114 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (7.02) | 18.7374 |
1990's | 3 (2.63) | 18.2507 |
2000's | 22 (19.30) | 29.6817 |
2010's | 48 (42.11) | 24.3611 |
2020's | 33 (28.95) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Mustard, JF; Packham, MA | 1 |
Bentur, L; Bryan, AC; England, S; Kerem, E; Levison, H; O'Brodovich, H; Reisman, J | 1 |
Abdou, NI; Becker, NJ; Crockett, RS; Valenzeno, DP | 1 |
Miescher, PA | 1 |
Kitridou, RC; Solomon, SD | 1 |
Burnham, TK; Fine, G; Lester, RS; Murray, K | 1 |
Lesowitz, SA; Roenigk, HH | 1 |
Klaiman, MD; Miller, SD | 1 |
Battesti, JP; Brauner, M; Clerici, C; Lavergne, F; Sadoun, D; Valeyre, D | 1 |
Ahmed, W; Maddison, PJ; Seale, JR; Thorpe, C; Whiteley, GS | 1 |
Barland, P; Peeva, E | 1 |
Becvár, R; Hercogová, J; Mandys, V; Petrovská, P; Pock, L | 1 |
Arnal, C; Bierling, P; Godeau, B; Hachulla, E; Léone, J; Papo, T; Piette, JC; Roudot-Thoraval, F; Schaeffer, A; Taillan, B | 1 |
Lindsley, CB; Samad, AS | 1 |
GREENWALD, ES | 1 |
Conaghan, PG; Emery, P; Green, MJ; Karim, Z; Marzo-Ortega, H; Proudman, S; Quinn, MA; Wakefield, RJ | 1 |
André, J; Bourguignon, R; de la Brassinne, M; Richert, B | 1 |
Constantin, E; Dancey, P; Duffy, CM; Scuccimarri, R | 1 |
Chang, DM; Chen, CH; Chen, HC; Gao, HW; Huang, GS; Kuo, SY; Lai, JH | 1 |
Celik, Y; Gerenli, M; Pamuk, ON; Soy, M | 1 |
Cacciatore, P; D'Amico, E; Olivieri, I; Palazzi, C; Pennese, E | 1 |
Hong, SJ; Huh, J; Jang, JY; Kim, HB; Kim, JH; Lee, SY; Park, SJ | 1 |
Lesiak, A; McCauliffe, DP; Salamon, M; Sysa-Jedrzejowska, A; Wozniacka, A | 1 |
Dold, S; Espinoza, LR; Justiniano, ME; Marquez, J | 1 |
Aydog, E; Sever, A; Usan, H; Yesilli, O | 1 |
Aslanidis, S; Kartali, N; Pyrpasopoulou, A; Zamboulis, C | 1 |
Brown, AK; Conaghan, PG; Emery, P; Green, MJ; Hensor, EM; Karim, Z; Quinn, MA; Wakefield, RJ | 1 |
Aydintuğ, OT; Batioğlu, F; Heper, AO; Ozmert, E; Taner, P | 1 |
Bathelier, E; Blanc-Lasserre, K; Geffroy, D; Kanitakis, J; Labeille, B; Truchot, F; Zenone, T | 1 |
Feliu, E; Gonzàlez, N; Jové, J; Olivé, A; Ribera, JM; Xicoy, B | 1 |
Lieberman, SM; Sherry, DD | 1 |
Chung, IK; Kim, HS; Kim, SJ; Lee, CK; Lee, SH; Lee, TH; Park, SH | 1 |
Gupta, D; Gupta, K; Rajagopala, S; Singh, N | 1 |
Beers, MF; Griese, M; Hartl, D; Hector, A; Kern, S; Liebisch, G; Mulugeta, S; Schmitz, G; Sparr, C; Thurm, T; Woischnik, M | 1 |
Anouti, S; Haddad, F; Koussa, S; Maalouly, G | 1 |
Balbir-Gurman, A; Bergman, R; Braun-Moscovici, Y; Egozi, D; Markovits, D; Melamed, Y; Ramon, Y; Rozin, AP; Schapira, D; Toledano, K; Ullman, Y | 1 |
Tao, XJ; Wang, W; Yu, JN | 1 |
David, J; Mankia, KS | 1 |
Amoura, Z; Barete, S; Benveniste, O; Bourgeois, P; Cacoub, P; Dubourg, O; Francès, C; Gatfossé, M; Lebeaux, D; Maisonobe, T; Piette, JC; Renoux, J; Sène, D; Wechsler, B | 1 |
Abouzahir, A; Amezyane, T; Elomri, N; Elqatni, M; Fatihi, J; Ghafir, D; Mekouar, F; Sekkach, Y | 1 |
Audia, S; Berthier, S; Bonnotte, B; Janikashvili, N; Leguy, V; Lorcerie, B; Martin, L; Samson, M | 1 |
Bairey Merz, CN; Berman, DS; Goykhman, P; Ishimori, ML; Mehta, PK; Minissian, M; Shufelt, CL; Thomson, LE; Wallace, DJ; Weisman, MH | 1 |
Griese, M; Hartl, D; Hector, A; Kaltenborn, E; Kern, S; Liebisch, G; Schmitz, G; Sparr, C; Thurm, T; Woischnik, M; Zarbock, R | 1 |
Bush, A; Fitch, JA; Hayes, D; Lloyd, EA | 1 |
Berner, R; Geiger, J; Heinzmann, A; Hufnagel, M; Meinicke, H | 1 |
Foroughipour, M; Nikbin, Z; Pezeshki Rad, M; Sahebari, M; Shoeibi, A | 1 |
Dettori, PN; Hertimian, ML; Manzella, DJ; Melero, MJ | 1 |
Fan, LL; Farahmand, V; Ischander, M; Langston, C; Yazdani, S | 1 |
Erten, S; Taskaldiran, I; Yakut, ZI | 1 |
Bozkirli, DE; Bozkirli, E; Kozanoglu, I; Yucel, E | 1 |
Danza, A; Delgado, S; Garcia, M; Khamashta, M; Perales, I; Ruiz-Irastorza, G; Villar, I | 1 |
Arıkan-Ayyıldız, Z; Caglayan-Sozmen, S; Couderc, R; Deterding, R; Dishop, MK; Epaud, R; Isık, S; Louha, M; Uzuner, N | 1 |
Canavan, T; Doan, LT; Ricardo-Gonzalez, RR; Rosenblum, MD; Shen, G; Sidorsky, T | 1 |
Jiang, Y; Jiang, Z; Ma, H; Ma, N; Zhao, L | 1 |
Biswas, M; Chatterjee, S; Ghosh, A; Ghosh, S; Sarkate, P | 1 |
Boura, P; Gkougkourelas, I; Sarantopoulos, A; Tselios, K | 1 |
Arroyo-Ávila, M; Vilá, LM | 1 |
Azón Masoliver, A; Català Pérez, R; Hernández Flix, S | 1 |
Martínez-Morillo, M; Olivé, A; Prior-Español, Á; Riveros-Frutos, A | 1 |
Barbosa, C; Ruiz-Arruza, I; Ruiz-Irastorza, G; Ugarte, A | 1 |
Bellakhal, S; Ben Kaab, B; Derbel, F; Douggui, MH; Souissi, A; Teyeb, Z | 1 |
Chen, GS; Hu, SC; Lin, CL; Lin, YC; Wang, TN; Yen, FL | 1 |
Adelowo, OO; Akintayo, RO; Animashaun, BA; Olaosebikan, BH | 1 |
Jiang, Z; Jing, W; Ma, H; Ye, Z; Yuan, Y | 1 |
Antaya, RJ; Li, AW; Stamey, CR; Subtil, A; Tomayko, MM; Weed, JG | 1 |
Jasarovic, D; Lazovic, B; Stevanovic, D; Zlatkovic-Svenda, M | 1 |
Chosidow, O; de Prost, N; Dumas, M; Duong, TA; Fardet, L; Hotz, C; Hua, C; Hüe, S; Ingen-Housz-Oro, S; Maraffi, T; Ortonne, N; Velter, C; Wolkenstein, P | 1 |
Breuer, O; Schultz, A | 1 |
Danza, A; Ruiz-Irastorza, G; Ugarte, A | 1 |
Tekin, ZE; Yener, GO; Yüksel, S | 1 |
Castner, NB; Harris, JC; Motaparthi, K | 1 |
Cox, A; Heaton, V; Munro, J; Renton, WD; Samuel, C; Soh, HJ | 1 |
Chen, CH; Chou, YC; Huang, WY; Ju, UH; Kao, CH; Lin, CL; Lin, CS; Lin, KT; Lin, TY; Liu, FC; Shen, CH; Yang, TY | 1 |
Gamlaksha, D; Karunarathna, T; Kulatunga, A; Liyadipita, A; Matthias, T; Piranavan, P; Shanjeeban, P; Vithoosan, S | 1 |
Ping, X; Ramlagun, D; Shadhu, K | 1 |
Blanco, P; Duffau, P; Lazaro, E; Martin-Cascon, M; Richez, C; Ruiz-Arruza, I; Ruiz-Estevez, B; Ruiz-Irastorza, G; Ugarte, A | 1 |
Cai, QQ; Chen, P; Chen, YQ; Liu, LJ; Lv, JC; Shi, SF; Yang, YZ; Zhang, H | 1 |
Castillo Dayer, PV; Lozano Rivas, N; Marras Fernández-Cid, C; Martínez Ferrín, JJ; Sánchez-Pedreño Guillen, P; Victoria Martínez, AM | 1 |
Gao, M; Jiang, Y; Sheng, N; Yang, X | 1 |
Brites, L; Luis, M; Rodrigues, M; Santiago, M | 1 |
Duru Çetinkaya, P | 1 |
Bagalà, A; Bartiromo, M; Bartoloni, A; Borchi, B; Botta, A; Bresci, S; Cavallo, A; Cirami, C; Cutruzzulà, R; Larti, A; Lugli, G; Tilli, M; Vaglio, A; Xhaferi, B | 1 |
Aajal, A; Ait Brik, A; Ammour, O; Benajiba, C; El Boussadani, B; El Hangouch, J; Oussama, B; Oussama, O; Raissuni, Z; Tahiri, N | 1 |
Anselmi, E; Cavanna, L; Citterio, C; Codeluppi, M; Stroppa, EM; Toscani, I; Zaffignani, E | 1 |
Ashton, NJ; Blennow, K; Caruso, A; Castelli, F; Comelli, A; Focà, E; Gasparotti, R; Gazzina, S; Leonardi, M; Masciocchi, S; Nocivelli, S; Odolini, S; Padovani, A; Pasolini, MP; Pezzini, A; Pilotto, A; Volonghi, I; Zetterberg, H | 1 |
Afshar, H; Aloosh, O; Emamikhah, M; Kalantari, S; Lotfi, T; Moghaddasi, M; Sadeghipour, A; Yassin, Z | 1 |
Cai, S; Dong, L; Li, M; Sun, W | 1 |
Cham, S; Chen, TY; Farghaly, S; Rauda, R; Ribisi, M; Sin, JH; Sumrani, N; Tatem, LL | 1 |
Fustini, E; Gennarini, S; Mattioli, M | 1 |
Allison, D; Campbell-Lee, S; Crane, J; Fraidenburg, D; Hussain, F; Vidanovic, V; Webb, S | 1 |
Albano, J; Azmaiparashvili, Z; Elbashabsheh, M; Gul, F; Hiedra, R; Lo, KB; Patarroyo Aponte, G; Wright, RM | 1 |
Constantinides, VC; Deligianni, C; Dimitrakopoulos, A; Kapaki, E; Paraskevas, GP | 1 |
Argyraki, A; Boletis, I; Grigorakos, K; Lourida, P; Marinaki, S; Skalioti, C; Tsiakas, S | 1 |
Alessandrini, AI; Baldi, F; Balletto, E; Barisione, E; Bassetti, M; Beltramini, S; Berruti, M; Briano, F; Bruzzone, B; Camera, M; Da Rin, G; De Maria, A; Delfino, E; Dentone, C; Dettori, S; Di Biagio, A; Dodi, F; Ferrazin, A; Giacobbe, DR; Giacomini, M; Gratarola, A; Icardi, G; Labate, L; Magnasco, L; Mazzarello, G; Mikulska, M; Mirabella, M; Mora, S; Nicolini, LA; Orsi, A; Pelosi, P; Pincino, R; Portunato, F; Rosseti, N; Russo, C; Sasso, E; Schenone, E; Sepulcri, C; Signori, A; Sormani, MP; Taramasso, L; Toscanini, F; Tutino, S; Vena, A | 1 |
Fujii, H; Hiraoka, N; Horiguchi, M; Matsuyama, A; Omura, A; Ono, S; Shiotsu, S; Suga, Y; Takumi, C; Tanaka, S; Tsuji, T; Yuba, T | 1 |
Alcobendas, R; Álvarez-Rojas, E; de la Serna, O; Laplaza-González, M; Murias, S; Quintana-Ortega, C; Remesal, A; Ruiz de Valbuena, M; Udaondo, C | 1 |
Arevalo-Serrano, J; Garcia-Gomez, C; Jimenez-Vizuete, JM; Martinez-Alfaro, E; Rodriguez-Garcia, JL; Sanchez-Nievas, G | 1 |
Brusasco, C; Brusasco, V; Corradi, F; Di Domenico, A; Raggi, F; Santori, G; Timossi, G | 1 |
Mamishi, S; Navaeian, A; Shabanian, R | 1 |
Carvalho, JF; Shoenfeld, Y; Silva, FF | 1 |
Ackerman, L; Brahmbhatt, S; Coleman, I; Ruiz, G | 1 |
Charan, N; Kam, JK; Leong, RW; Loh, ZW; Thong, BY | 1 |
Alhashmi, A; Belfaqeeh, O; Janapala, RN; Patel, J; Pourmand, A | 1 |
Uslu, S | 1 |
Alotaibi, NH; Bokharee, N; Khan, YH; Khokhar, A; Mallhi, TH; Rasheed, M | 1 |
Bodin, R; Dale, M; Diflo, T; John, D; Latifi, R; Nishida, S; Nog, R; Partiula, B; Seyedsaadat, SM; Sogawa, H; Veillette, G; Wolf, DC | 1 |
Alkan, M; Demirkol, MA; Dinc, V; Esatoglu, SN; Kamat, S; Kostek, ME; Sargin Altunok, E; Satici, C; Toprak, ID; Yazla, S | 1 |
Duarte-García, A; Williamson, KA; Yang, JX | 1 |
Asturkar, V; Bhanu, K; Dorji, T; Hegde, A; Yangzom, S | 1 |
He, J; Liu, T; Xiao, X; Zhou, W | 1 |
Giarolla, J; Parise-Filho, R; Polli, MC; Vassiliades, SV; Vaz, ES | 1 |
20 review(s) available for methylprednisolone and hydroxychloroquine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Clinical pharmacology of platelets.
Topics: Adenosine Diphosphate; Aspirin; Blood Coagulation; Blood Platelets; Cell Membrane; Clofibrate; Cyproheptadine; Dipyridamole; Drug Therapy, Combination; Furosemide; Halofenate; Heparin; Humans; Hydrocortisone; Hydroxychloroquine; Methylprednisolone; Penicillin G; Platelet Aggregation; Propranolol; Prostaglandins; Sulfinpyrazone; Vitamin E | 1977 |
Treatment of systemic lupus erythematosus.
Topics: Azathioprine; Cyclophosphamide; Cyclosporins; Drug Therapy, Combination; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Methylprednisolone; Plasmapheresis; Steroids | 1986 |
The patient with rheumatoid arthritis.
Topics: Activities of Daily Living; Arthritis, Rheumatoid; Bursitis; Chloroquine; Diagnosis, Differential; Finger Joint; Gold; Gout; Hot Temperature; Humans; Hydroxychloroquine; Methylprednisolone; Neuralgia; Osteoarthritis; Pain; Physical Examination; Physical Exertion; Physical Therapy Modalities; Prednisolone; Rest; Salicylates; Synovectomy; Triamcinolone; Wrist Joint | 1971 |
Transverse myelitis complicating systemic lupus erythematosus: treatment including hydroxychloroquine. Case report.
Topics: Adult; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Magnetic Resonance Imaging; Methylprednisolone; Myelitis, Transverse; Prednisone; Quadriplegia | 1993 |
Systemic lupus erythematosus with simultaneous onset of Kikuchi-Fujimoto's disease complicated with antiphospholipid antibody syndrome: a case report and review of the literature.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents; Anticoagulants; Antiphospholipid Syndrome; Antirheumatic Agents; Aspirin; Azathioprine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Heparin; Histiocytic Necrotizing Lymphadenitis; Humans; Hydroxychloroquine; Injections, Intravenous; Lupus Erythematosus, Systemic; Male; Methylprednisolone; Treatment Outcome; Venous Thrombosis | 2005 |
Pulmonary amyloidosis in Sjogren's syndrome: a case report and systematic review of the literature.
Topics: Adrenal Cortex Hormones; Adult; Amyloidosis; Anti-Bacterial Agents; Antitubercular Agents; Biopsy; Escherichia coli Infections; Female; Humans; Hydroxychloroquine; Hypoxia; Klebsiella Infections; Klebsiella pneumoniae; Lung Diseases; Methylprednisolone; Mycobacterium tuberculosis; Radiography; Sjogren's Syndrome; Tuberculosis, Pulmonary | 2010 |
Are systemic lupus erythematosus patients carrying MEFV gene less prone to renal involvement? Report of three cases and review of the literature.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Antirheumatic Agents; Colchicine; Cytoskeletal Proteins; Familial Mediterranean Fever; Female; Heterozygote; Humans; Hydroxychloroquine; Kidney; Kidney Function Tests; Lupus Erythematosus, Systemic; Methylprednisolone; Mutation; Patient Acuity; Pyrin; Treatment Outcome; Tubulin Modulators | 2013 |
Cardiac tamponade in a patient with mixed connective tissue disease.
Topics: Anti-Inflammatory Agents; Antirheumatic Agents; Cardiac Tamponade; Drug Therapy, Combination; Echocardiography; Female; Humans; Hydroxychloroquine; Methylprednisolone; Middle Aged; Mixed Connective Tissue Disease; Pericardial Effusion; Pericardium; Prednisone; Treatment Outcome | 2015 |
Comparison of high versus low-medium prednisone doses for the treatment of systemic lupus erythematosus patients with high activity at diagnosis.
Topics: Glucocorticoids; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Methylprednisolone; Prednisone | 2015 |
Side effects of medications used to treat childhood interstitial lung disease.
Topics: Anti-Bacterial Agents; Antirheumatic Agents; Azithromycin; Child; Cyclophosphamide; Glucocorticoids; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lung Diseases, Interstitial; Methotrexate; Methylprednisolone; Off-Label Use; Prednisolone; Rituximab | 2018 |
Glucocorticoids and antimalarials in systemic lupus erythematosus: an update and future directions.
Topics: Antimalarials; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Methylprednisolone; Prednisone; Quinacrine; Treatment Outcome | 2018 |
Acquired angioedema in juvenile systemic lupus erythematosus: case-based review.
Topics: Adolescent; Angioedema; Complement C1 Inactivator Proteins; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Methylprednisolone | 2018 |
Cyclosporine for corticosteroid-refractory acute generalized exanthematous pustulosis due to hydroxychloroquine.
Topics: Acute Generalized Exanthematous Pustulosis; Cyclosporine; Dermatologic Agents; Female; Glucocorticoids; Humans; Hydroxychloroquine; Methylprednisolone; Middle Aged; Prednisone; Retreatment | 2018 |
Challenges in the diagnosis and treatment of disabling pansclerotic morphea of childhood: case-based review.
Topics: Antirheumatic Agents; Biological Products; Biopsy; Child, Preschool; Contracture; Edema; Hematopoietic Stem Cell Transplantation; Humans; Hydroxychloroquine; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Janus Kinase Inhibitors; Male; Methylprednisolone; Mycophenolic Acid; Prednisolone; Protein Kinase Inhibitors; Scleroderma, Localized; Scleroderma, Systemic; Skin; Synovitis; Treatment Failure; Treatment Outcome | 2019 |
[COVID-19 pandemia: Impact on the cariovascular system. Data of 1
Topics: Antimalarials; Antiviral Agents; Azithromycin; Betacoronavirus; Cardiomyopathies; Cardiovascular Diseases; Cerebrovascular Disorders; Chloroquine; Comorbidity; Coronary Disease; Coronavirus Infections; COVID-19; Drug Interactions; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Methylprednisolone; Pandemics; Pneumonia, Viral; Risk Factors; SARS-CoV-2; Virus Internalization | 2020 |
A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab.
Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Antirheumatic Agents; Antiviral Agents; Arthritis, Rheumatoid; Aspergillosis; Aspergillus fumigatus; Betacoronavirus; Coronavirus Infections; Cough; COVID-19; Cytokine Release Syndrome; Deprescriptions; Disease Progression; Dyspnea; Female; Glucocorticoids; Humans; Hydroxychloroquine; Immunocompromised Host; Immunosuppressive Agents; Interleukin-6; Leflunomide; Lung; Lymphohistiocytosis, Hemophagocytic; Methylprednisolone; Oxygen Inhalation Therapy; Pandemics; Pneumocystis carinii; Pneumonia, Pneumocystis; Pneumonia, Viral; Pulmonary Aspergillosis; Recurrence; SARS-CoV-2; Tomography, X-Ray Computed | 2020 |
High levels of anti-SSA/Ro antibodies in COVID-19 patients with severe respiratory failure: a case-based review : High levels of anti-SSA/Ro antibodies in COVID-19.
Topics: Aged; Amides; Antibodies, Antinuclear; Antiviral Agents; Benzamidines; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Glucocorticoids; Guanidines; Humans; Hydroxychloroquine; Lung Diseases, Interstitial; Male; Methylprednisolone; Pandemics; Pneumonia, Viral; Pregnenediones; Pyrazines; Recovery of Function; Respiratory Distress Syndrome; Respiratory Insufficiency; SARS-CoV-2; Severity of Illness Index; Tomography, X-Ray Computed | 2020 |
Pharmacological interventions for COVID-19: a systematic review of observational studies and clinical trials.
Topics: Adenosine Monophosphate; Alanine; Amides; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antimalarials; Antiviral Agents; Chloroquine; Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Humans; Hydroxychloroquine; Immunization, Passive; Indoles; Intensive Care Units; Length of Stay; Lopinavir; Methylprednisolone; Observational Studies as Topic; Patient Admission; Pyrazines; Ritonavir; SARS-CoV-2; Survival Rate | 2021 |
Drug repositioning in the COVID-19 pandemic: fundamentals, synthetic routes, and overview of clinical studies.
Topics: Antiviral Agents; Azithromycin; Chloroquine; COVID-19; Dexamethasone; Drug Repositioning; Humans; Hydroxychloroquine; Ivermectin; Methylprednisolone; Pandemics; Reproducibility of Results; SARS-CoV-2 | 2023 |
2 trial(s) available for methylprednisolone and hydroxychloroquine
Article | Year |
---|---|
Treatment of severe immune thrombocytopenia associated with systemic lupus erythematosus: 59 cases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cohort Studies; Danazol; Drug Administration Routes; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Immunoglobulin G; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Methylprednisolone; Middle Aged; Prednisone; Purpura, Thrombocytopenic, Idiopathic; Recurrence; Retrospective Studies; Splenectomy; Treatment Outcome | 2002 |
Systemic lupus erythematosus complicated with femoral head ischemic necrosis treated by Chinese medicine therapy for activating blood and dredging collaterals method.
Topics: Adolescent; Adult; Blood Circulation; Collateral Circulation; Combined Modality Therapy; Cyclophosphamide; Drugs, Chinese Herbal; Female; Femur Head Necrosis; Humans; Hydroxychloroquine; Immunosuppressive Agents; Ischemia; Lupus Erythematosus, Systemic; Male; Medicine, Chinese Traditional; Methylprednisolone; Middle Aged; Treatment Outcome; Up-Regulation; Young Adult | 2011 |
92 other study(ies) available for methylprednisolone and hydroxychloroquine
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Sequential pulmonary function measurements during treatment of infantile chronic interstitial pneumonitis.
Topics: Airway Resistance; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Infant; Lung Compliance; Male; Methylprednisolone; Pulmonary Fibrosis; Respiratory Function Tests; Time Factors | 1990 |
Effect of in vitro ultraviolet radiation on the binding capacity of anti-DNA and DNA in systemic lupus erythematosus.
Topics: Antibodies, Antinuclear; Antibody Affinity; Chromosome Aberrations; DNA; Enzyme-Linked Immunosorbent Assay; Humans; Hydroxychloroquine; In Vitro Techniques; Indomethacin; Lupus Erythematosus, Systemic; Methylprednisolone; Ultraviolet Rays | 1989 |
[Corticotherapy in rheumatoid polyarthritis].
Topics: Adrenocorticotropic Hormone; Aged; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Betamethasone; Chlorambucil; Cortisone; Dexamethasone; Diabetes Mellitus; Female; Gastrointestinal Diseases; Glucocorticoids; Gold; Humans; Hydroxychloroquine; Hypertension; Male; Methylprednisolone; Middle Aged; Paramethasone; Prednisolone; Prednisone; Triamcinolone | 1971 |
Immunologic concepts of light reactions in lupus erythematosus and polymorphous light eruptions. I. The mechanism of action of hydroxychloroquine.
Topics: Antibodies, Antinuclear; Autoantibodies; Chloroquine; DNA; Erythema; Humans; Hydralazine; Hydroxychloroquine; Injections, Intradermal; Lupus Erythematosus, Discoid; Lupus Erythematosus, Systemic; Methotrexate; Methylprednisolone; Prednisone; Protein Binding; Skin Manifestations; Ultraviolet Rays | 1967 |
Lymphocytoma cutis.
Topics: Humans; Hydroxychloroquine; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Skin Neoplasms | 1970 |
Airway obstruction in bronchial sarcoidosis: outcome with treatment.
Topics: Administration, Oral; Adult; Airway Obstruction; Antirheumatic Agents; Biopsy; Bronchial Diseases; Bronchoscopy; Female; Follow-Up Studies; Glucocorticoids; Humans; Hydroxychloroquine; Male; Methotrexate; Methylprednisolone; Middle Aged; Radiography, Thoracic; Respiratory Function Tests; Retrospective Studies; Sarcoidosis, Pulmonary; Treatment Outcome | 1999 |
'Catastrophic' antiphospholipid syndrome.
Topics: Anti-Inflammatory Agents; Anticoagulants; Antiphospholipid Syndrome; Antirheumatic Agents; Critical Illness; Female; Humans; Hydroxychloroquine; Methylprednisolone; Middle Aged; Prednisolone; Respiratory Distress Syndrome; Treatment Outcome; Warfarin; White People | 2000 |
Sensorineural hearing loss in conjunction with aortic insufficiency in systemic lupus erythematosus.
Topics: Adult; Antirheumatic Agents; Aortic Valve Insufficiency; Female; Glucocorticoids; Hearing Loss, Sensorineural; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Methylprednisolone; Middle Aged | 2001 |
Verrucous form of chilblain lupus erythematosus.
Topics: Biopsy, Needle; Chilblains; Female; Follow-Up Studies; Foot Dermatoses; Hand Dermatoses; Humans; Hydroxychloroquine; Keratosis; Lupus Erythematosus, Cutaneous; Methylprednisolone; Middle Aged; Mouth Mucosa; Risk Assessment; Treatment Outcome | 2001 |
Treatment of pulmonary hemorrhage in childhood systemic lupus erythematosus with mycophenolate mofetil.
Topics: Adolescent; Combined Modality Therapy; Disease Progression; Drug Therapy, Combination; Hemorrhage; Humans; Hydroxychloroquine; Immunosuppressive Agents; Infusions, Intravenous; Lung Diseases; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Methylprednisolone; Mycophenolic Acid; Plasmapheresis; Prednisone; Respiration, Artificial | 2003 |
SYSTEMIC LUPUS ERYTHEMATOSUS: TREATMENT WITH ANTIMALARIAL DRUGS.
Topics: Antimalarials; Chloroquine; Dexamethasone; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Methylprednisolone; Prednisone; Triamcinolone | 1964 |
Prognostic factors in a large cohort of patients with early undifferentiated inflammatory arthritis after application of a structured management protocol.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis; Clinical Protocols; Cohort Studies; Female; Hand; Health Status; Humans; Hydroxychloroquine; Injections, Intra-Articular; Injections, Intramuscular; Male; Methotrexate; Methylprednisolone; Middle Aged; Rheumatoid Factor; Severity of Illness Index; Sulfasalazine; Treatment Outcome | 2003 |
Hyperkeratotic nail discoid lupus erythematosus evolving towards systemic lupus erythematosus: therapeutic difficulties.
Topics: Dermatologic Agents; Diagnosis, Differential; Drug Therapy, Combination; Fingers; Hand Dermatoses; Humans; Hydroxychloroquine; Isotretinoin; Lupus Erythematosus, Discoid; Lupus Erythematosus, Systemic; Male; Methylprednisolone; Middle Aged; Nail Diseases | 2004 |
Lupus cystitis in association with severe gastrointestinal manifestations in an adolescent.
Topics: Adolescent; Antirheumatic Agents; Azathioprine; Cystitis, Interstitial; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Humans; Hydroxychloroquine; Immunosuppressive Agents; Injections, Intravenous; Lupus Erythematosus, Systemic; Methylprednisolone; Pulse Therapy, Drug; Tomography, X-Ray Computed; Treatment Outcome | 2005 |
A primary Sjögren's syndrome patient with distal renal tubular acidosis, who presented with symptoms of hypokalemic periodic paralysis: Report of a case study and review of the literature.
Topics: Acidosis, Renal Tubular; Adult; Antirheumatic Agents; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Hypokalemic Periodic Paralysis; Methylprednisolone; Potassium; Potassium Deficiency; Sjogren's Syndrome; Treatment Outcome; Xerophthalmia; Xerostomia | 2005 |
Non-rheumatoid erosive arthritis associated with type I hereditary angioedema.
Topics: Angioedema; Antirheumatic Agents; Arthritis; Arthroplasty, Replacement, Hip; Female; Hip Joint; Humans; Hydroxychloroquine; Methylprednisolone; Middle Aged; Remission Induction; Treatment Outcome; Wrist Joint | 2005 |
Familial interstitial lung disease in two young Korean sisters.
Topics: Child, Preschool; Female; Humans; Hydroxychloroquine; Infant; Korea; Lung Diseases, Interstitial; Methylprednisolone; Siblings; Tomography, X-Ray Computed | 2005 |
The dynamism of cutaneous lupus erythematosus: mild discoid lupus erythematosus evolving into SLE with SCLE and treatment-resistant lupus panniculitis.
Topics: Antimalarials; Azathioprine; Cyclophosphamide; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Methotrexate; Methylprednisolone; Middle Aged; Panniculitis, Lupus Erythematosus; Pulse Therapy, Drug; Tacrolimus; Treatment Failure | 2007 |
Treatment of early and refractory dermatomyositis with infliximab: a report of two cases.
Topics: Adult; Antibodies, Monoclonal; Dermatologic Agents; Dermatomyositis; Drug Resistance; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Hydroxychloroquine; Infliximab; Methylprednisolone; Prednisone; Treatment Outcome | 2007 |
Dermatitis herpetiformis and rheumatoid arthritis.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Dapsone; Dermatitis Herpetiformis; Epidermis; Humans; Hydroxychloroquine; Male; Methotrexate; Methylprednisolone; Middle Aged | 2006 |
Successful treatment of refractory rash in paraneoplastic amyopathic dermatomyositis.
Topics: Adult; Dermatomyositis; Drug Therapy, Combination; Exanthema; Female; Glucocorticoids; Humans; Hydroxychloroquine; Immunoglobulins, Intravenous; Methylprednisolone; Paraneoplastic Syndromes; Prednisolone; Skin; Treatment Outcome | 2007 |
Response to intramuscular methyl prednisolone in inflammatory hand pain: evidence for a targeted clinical, ultrasonographic and therapeutic approach.
Topics: Adult; Anti-Inflammatory Agents; Antirheumatic Agents; Female; Hand; Humans; Hydroxychloroquine; Injections, Intramuscular; Male; Methylprednisolone; Middle Aged; Pain; Treatment Outcome | 2007 |
Recurrent optic disc and retinal vasculitis in a patient with drug-induced urticarial vasculitis.
Topics: Anti-Infective Agents; Dermatologic Agents; Drug Industry; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Hydroxychloroquine; Methylprednisolone; Middle Aged; Optic Disk; Pulse Therapy, Drug; Recurrence; Retinal Vasculitis; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Urticaria; Vasculitis, Leukocytoclastic, Cutaneous | 2006 |
[Lupus profundus and myelopathy].
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Dermatologic Agents; Female; Humans; Hydroxychloroquine; Methylprednisolone; Myelitis; Panniculitis, Lupus Erythematosus; Prednisone | 2006 |
Systemic lupus erythematosus in a patient with primary MALT lymphoma of the larynx.
Topics: Adult; Female; Glucocorticoids; Humans; Hydroxychloroquine; Laryngeal Neoplasms; Lupus Erythematosus, Systemic; Lymphoma, B-Cell, Marginal Zone; Methylprednisolone; Neoplasms, Radiation-Induced; Treatment Outcome | 2009 |
Development of classic dermatomyositis rash years after diagnosis of juvenile polymyositis.
Topics: Anti-Inflammatory Agents; Child; Dermatomyositis; Disease Progression; Drug Therapy, Combination; Exanthema; Humans; Hydroxychloroquine; Male; Methylprednisolone; Prednisone; Time Factors; Treatment Outcome | 2009 |
GI vasculitis associated with systemic lupus erythematosus.
Topics: Administration, Oral; Anti-Inflammatory Agents; Colon; Colonic Diseases; Colonoscopy; Diagnosis, Differential; Female; Humans; Hydroxychloroquine; Infusions, Intravenous; Intestinal Mucosa; Ischemia; Lupus Erythematosus, Systemic; Mesenteric Ischemia; Methylprednisolone; Prednisolone; Systemic Vasculitis; Tomography, X-Ray Computed; Vascular Diseases; Young Adult | 2010 |
A non-BRICHOS surfactant protein c mutation disrupts epithelial cell function and intercellular signaling.
Topics: Amino Acid Substitution; Animals; Azathioprine; Bronchoalveolar Lavage Fluid; Calnexin; Calreticulin; CD4-Positive T-Lymphocytes; Cell Line; Cyclophosphamide; Epithelial Cells; HSP70 Heat-Shock Proteins; HSP90 Heat-Shock Proteins; Humans; Hydroxychloroquine; Lung Diseases, Interstitial; Methylprednisolone; Mice; Mutation; Phosphatidylcholines; Pulmonary Surfactant-Associated Protein C; Receptors, CCR2; Receptors, Interleukin-8A; Signal Transduction | 2010 |
[Narcolepsy associated with systemic lupus erythematosus].
Topics: Adult; Aspirin; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Maintenance Chemotherapy; Methylprednisolone; Narcolepsy; Prednisone | 2011 |
Large leg ulcers due to autoimmune diseases.
Topics: Animals; Antibodies, Monoclonal; Autoimmune Diseases; Azathioprine; Ciprofloxacin; Cyclophosphamide; Cyclosporine; Female; Humans; Hydroxychloroquine; Hyperbaric Oxygenation; Infliximab; Larva; Leg Ulcer; Male; Methylprednisolone; Middle Aged; Prednisolone; Skin Transplantation; Treatment Outcome; Vancomycin; Vasculitis; Young Adult | 2011 |
A diagnosis of sarcoid arthritis: 'check the tattoos'.
Topics: Adult; Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis; Drug Therapy, Combination; Humans; Hydroxychloroquine; Lymph Nodes; Lymphatic Diseases; Male; Methylprednisolone; Sarcoidosis; Skin Diseases; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Eosinophilic fasciitis (Shulman disease): new insights into the therapeutic management from a series of 34 patients.
Topics: Adult; Aged; Antirheumatic Agents; Azathioprine; Colchicine; Drug Therapy, Combination; Eosinophilia; Female; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Male; Methotrexate; Methylprednisolone; Middle Aged; Prednisone; Prognosis; Remission Induction; Retrospective Studies; Scleroderma, Localized; Synovitis; Treatment Outcome | 2012 |
[Haemophagocytic syndrome as a complication of acute pancreatitis during systemic lupus erythematosus].
Topics: Abdomen, Acute; Autoantibodies; Female; Gingival Hemorrhage; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Lymphohistiocytosis, Hemophagocytic; Macrophage Activation; Methylprednisolone; Pancreatitis, Acute Necrotizing; Pancytopenia; Tomography, X-Ray Computed; Vomiting; Young Adult | 2012 |
Haemolytic-uraemic syndrome during severe lupus nephritis: efficacy of plasma exchange.
Topics: Acute Kidney Injury; Adult; Biopsy; Combined Modality Therapy; Cyclophosphamide; Drug Therapy, Combination; Erythrocytes, Abnormal; Female; Hemolytic-Uremic Syndrome; Humans; Hydroxychloroquine; Immunosuppressive Agents; Kidney; Lupus Nephritis; Methylprednisolone; Models, Immunological; Mycophenolic Acid; Plasma Exchange; Prednisone | 2012 |
Subendocardial ischemia and myocarditis in systemic lupus erythematosus detected by cardiac magnetic resonance imaging.
Topics: Anti-Inflammatory Agents; Benzimidazoles; Biphenyl Compounds; Chest Pain; Coronary Angiography; Coronary Vessels; Endocardium; Female; Humans; Hydroxychloroquine; Ischemia; Lupus Erythematosus, Systemic; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Myocarditis; Tetrazoles; Treatment Outcome | 2012 |
The surfactant protein C mutation A116D alters cellular processing, stress tolerance, surfactant lipid composition, and immune cell activation.
Topics: Animals; Azathioprine; Cell Line; Cyclophosphamide; Epithelial Cells; Gene Expression; Humans; Hydroxychloroquine; Lung Diseases, Interstitial; Methylprednisolone; Mice; Molecular Chaperones; Mutation; Phospholipids; Pulmonary Alveoli; Pulmonary Surfactant-Associated Protein C; Pulmonary Surfactants | 2012 |
ABCA3 transporter deficiency.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; ATP-Binding Cassette Transporters; Azithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Hydroxychloroquine; Infant, Newborn; Lung Diseases, Interstitial; Lung Transplantation; Male; Methylprednisolone; Pulmonary Alveolar Proteinosis; Respiration, Artificial; Respiratory Distress Syndrome, Newborn | 2012 |
Symptoms of shrinking lung syndrome reveal systemic lupus erythematosus in a 12-year-old girl.
Topics: Chest Pain; Child; Cyclophosphamide; Diaphragm; Dyspnea; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Methylprednisolone; Mycophenolic Acid; Pleurisy; Pulmonary Atelectasis; Radiography; Syndrome; Treatment Outcome | 2013 |
Devic syndrome: can antiphospholipid antibodies be a factor?
Topics: Adult; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Antirheumatic Agents; Aspirin; Atorvastatin; Azathioprine; Complement C4; Cyclophosphamide; Female; Glucocorticoids; Heparin; Heptanoic Acids; Humans; Hydroxychloroquine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulin G; Immunosuppressive Agents; Magnetic Resonance Imaging; Methylprednisolone; Neuromyelitis Optica; Plasmapheresis; Prednisolone; Pulse Therapy, Drug; Pyrroles; Warfarin | 2012 |
Chylous ascites and chylothorax as presentation of a systemic progression of discoid lupus.
Topics: Adult; Anti-Inflammatory Agents; Antirheumatic Agents; Chylothorax; Chylous Ascites; Disease Progression; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Discoid; Methylprednisolone; Paracentesis; Tomography, X-Ray Computed | 2013 |
Desquamative interstitial pneumonia in a child related to cigarette smoke.
Topics: Anti-Inflammatory Agents; Child; Humans; Hydroxychloroquine; Lung; Lung Diseases, Interstitial; Male; Methylprednisolone; Thoracic Surgery, Video-Assisted; Tobacco Smoke Pollution; Tomography, X-Ray Computed | 2014 |
Antisynthetase syndrome with refractory lung involvement and myositis successfully treated with double filtration plasmapheresis.
Topics: Aged; Autoantibodies; Azathioprine; Combined Modality Therapy; Creatine Kinase; Cyclophosphamide; Emergencies; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lung Diseases, Interstitial; Methylprednisolone; Myositis; Plasma; Plasmapheresis; Pulmonary Diffusing Capacity; Remission Induction | 2013 |
Prednisone in lupus nephritis: how much is enough?
Topics: Adult; Cyclophosphamide; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Kidney; Lupus Nephritis; Male; Methylprednisolone; Prednisone; Remission Induction | 2014 |
Survival of an infant with homozygous surfactant protein C (SFTPC) mutation.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Azithromycin; Consanguinity; Genes, Recessive; Homozygote; Humans; Hydroxychloroquine; Infant; Lung; Male; Methylprednisolone; Microscopy, Electron; Mutation, Missense; Oxygen Inhalation Therapy; Pedigree; Phenotype; Pulmonary Alveolar Proteinosis; Pulmonary Surfactant-Associated Protein C; Radiography; Respiration, Artificial; Respiratory Distress Syndrome; Siblings; Treatment Outcome | 2014 |
A case of Wong-type dermatomyositis with concomitant anti-MDA5 features.
Topics: Biomarkers; Biopsy, Needle; DEAD-box RNA Helicases; Dermatomyositis; Drug Therapy, Combination; Electromyography; Enzyme-Linked Immunosorbent Assay; Follow-Up Studies; Gene Expression Regulation; Humans; Hydroxychloroquine; Immunohistochemistry; Interferon-Induced Helicase, IFIH1; Male; Methylprednisolone; Middle Aged; Mycophenolic Acid; Pityriasis Rubra Pilaris; Rare Diseases; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2014 |
Immunoregulation therapy changes the frequency of interleukin (IL)-22+ CD4+ T cells in systemic lupus erythematosus patients.
Topics: Adolescent; Adult; CD4 Antigens; CD4-Positive T-Lymphocytes; Cell Differentiation; Cell Lineage; Cyclophosphamide; Female; Homeostasis; Humans; Hydroxychloroquine; Immunomodulation; Immunosuppressive Agents; Immunotherapy; Interferon-gamma; Interleukin-22; Interleukins; Lupus Erythematosus, Systemic; Male; Methylprednisolone; Th1 Cells; Young Adult | 2014 |
Early, structured disease modifying anti-rheumatic drug (DMARD) therapy reduces cardiovascular risk in rheumatoid arthritis--a single centre study using non-biologic drugs.
Topics: Adolescent; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; C-Reactive Protein; Cardiovascular Diseases; Carotid Intima-Media Thickness; Cholesterol; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Isoxazoles; Leflunomide; Male; Methotrexate; Methylprednisolone; Middle Aged; Severity of Illness Index; Sulfasalazine; Triglycerides; Young Adult | 2013 |
The influence of therapy on CD4+CD25(high)FOXP3+ regulatory T cells in systemic lupus erythematosus patients: a prospective study.
Topics: Adult; Azathioprine; CD4 Antigens; Cyclophosphamide; Female; Flow Cytometry; Forkhead Transcription Factors; Humans; Hydroxychloroquine; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interleukin-2 Receptor alpha Subunit; Lupus Erythematosus, Systemic; Male; Methylprednisolone; Middle Aged; Prospective Studies; Pulse Therapy, Drug; Remission Induction; T-Lymphocytes, Regulatory | 2015 |
[Interstitial lung disease induced by hydroxychloroquine].
Topics: Adult; Combined Modality Therapy; Female; Humans; Hydroxychloroquine; Lung Diseases, Interstitial; Methylprednisolone; Oxygen Inhalation Therapy; Photosensitivity Disorders; Skin Diseases, Genetic | 2015 |
[Recurrent diffuse alveolar hemorrhage in systemic lupus erytematosus treated with rituximab and immunoglobulins].
Topics: Cyclophosphamide; Drug Therapy, Combination; Hemorrhage; Humans; Hydroxychloroquine; Immunoglobulins, Intravenous; Immunosuppressive Agents; Lung Diseases; Lupus Erythematosus, Systemic; Male; Methylprednisolone; Prednisone; Recurrence; Remission Induction; Rituximab; Young Adult | 2015 |
[Systemic lupus erythematosus presenting as Stevens-Johnson syndrome].
Topics: Adult; Anemia; Arthralgia; Autoantibodies; Complement C3; Critical Care; Facial Dermatoses; Female; Humans; Hydroxychloroquine; Immunoglobulin G; Lupus Erythematosus, Systemic; Methylprednisolone; Mucositis; Prednisone; Stevens-Johnson Syndrome | 2015 |
Immunosuppressive medication use and risk of herpes zoster (HZ) in patients with systemic lupus erythematosus (SLE): A nationwide case-control study.
Topics: Administration, Intravenous; Administration, Oral; Adrenal Cortex Hormones; Adult; Azathioprine; Case-Control Studies; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Herpes Zoster; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Methotrexate; Methylprednisolone; Middle Aged; Mycophenolic Acid; Retrospective Studies; Risk Factors; Taiwan; Young Adult | 2016 |
Juvenile systemic lupus erythematosus in Nigeria.
Topics: Adolescent; Antibodies, Antinuclear; Antirheumatic Agents; Azathioprine; Child; Female; Hospitals, Teaching; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Male; Methylprednisolone; Nigeria; Retrospective Studies; Rituximab; Severity of Illness Index; Treatment Outcome | 2017 |
Interferon-stimulated gene 15 expression in systemic lupus erythematosus : Diagnostic value and association with lymphocytopenia.
Topics: Adult; Aged; Anemia; Case-Control Studies; Connective Tissue Diseases; Correlation of Data; Cytokines; Drug Therapy, Combination; Female; Follow-Up Studies; Gene Expression; Humans; Hydroxychloroquine; Immunosuppressive Agents; Infusions, Intravenous; Lupus Erythematosus, Systemic; Lymphopenia; Male; Methylprednisolone; Middle Aged; Polymerase Chain Reaction; RNA, Messenger; Ubiquitins; Young Adult | 2018 |
Bullous systemic lupus erythematosus in a 6-year-old boy.
Topics: Child; Enzyme Inhibitors; Glucocorticoids; Humans; Hydroxychloroquine; Lupus Erythematosus, Cutaneous; Male; Methylprednisolone; Mycophenolic Acid; Skin; Skin Diseases, Vesiculobullous | 2017 |
Systemic Lupus Erythematosus Presenting as Acute Lupus Pneumonitis.
Topics: Acute Disease; Aged; Chest Pain; Diagnosis, Differential; Dyspnea; Emergencies; Female; Fever; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Methylprednisolone; Pneumonia; Prednisone; Respiratory Tract Infections; Thoracentesis | 2018 |
Epidermal necrolysis and autoimmune diseases: two more observations supporting the concept that 'toxic' epidermal necrolysis can be 'non-toxic'.
Topics: Antibodies, Antinuclear; Autoimmune Diseases; Cyclophosphamide; Fatal Outcome; Female; Humans; Hydroxychloroquine; Methylprednisolone; Middle Aged; Prednisone; Stevens-Johnson Syndrome | 2018 |
Risk of Parkinson disease in Sjögren syndrome administered ineffective immunosuppressant therapies: A nationwide population-based study.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antirheumatic Agents; Comorbidity; Female; Humans; Hydroxychloroquine; Immunosuppression Therapy; Incidence; Male; Methylprednisolone; Middle Aged; Muscarinic Agonists; National Health Programs; Parkinson Disease; Pilocarpine; Quinuclidines; Retrospective Studies; Risk Factors; Sjogren's Syndrome; Taiwan; Thiophenes | 2019 |
Kikuchi-Fujimoto disease associated with systemic lupus erythematosus complicated with hemophagocytic lymphohistiocytosis: a case report.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Bone Marrow; Glucocorticoids; Histiocytic Necrotizing Lymphadenitis; Humans; Hydroxychloroquine; Indomethacin; Lupus Erythematosus, Systemic; Lymph Nodes; Lymphohistiocytosis, Hemophagocytic; Male; Methylprednisolone; Pancytopenia; Prednisolone | 2019 |
A rare case of laparoscopy towards SLE with lupus mesenteric vasculitis induced ascites.
Topics: Abdomen, Acute; Administration, Intravenous; Administration, Oral; Antirheumatic Agents; Ascites; Female; Glucocorticoids; Humans; Hydroxychloroquine; Laparoscopy; Lupus Erythematosus, Systemic; Mesentery; Methylprednisolone; Prognosis; Vasculitis; Young Adult | 2019 |
Prolonged remission in SLE is possible by using reduced doses of prednisone: An observational study from the Lupus-Cruces and Lupus-Bordeaux inception cohorts.
Topics: Administration, Oral; Adult; Cohort Studies; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; France; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Methotrexate; Methylprednisolone; Middle Aged; Prednisone; Remission Induction; Spain; Treatment Outcome; Young Adult | 2019 |
Comparison of the effects of hydroxychloroquine and corticosteroid treatment on proteinuria in IgA nephropathy: a case-control study.
Topics: Adrenal Cortex Hormones; Adult; Case-Control Studies; Female; Glomerular Filtration Rate; Glomerulonephritis, IGA; Humans; Hydroxychloroquine; Immunologic Factors; Male; Methylprednisolone; Prednisolone; Prednisone; Proteinuria | 2019 |
Belimumab treatment in rhupus: A case report with severe skin involvement.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Rheumatoid; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Methylprednisolone; Syndrome; Treatment Outcome | 2019 |
Plaque-like Cutaneous Lupus Mucinosis as the First Sign of Systemic Lupus Erythematosus.
Topics: Administration, Oral; Adult; Antirheumatic Agents; Biopsy; Diagnosis, Differential; Female; Glucocorticoids; Humans; Hydroxychloroquine; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic; Methylprednisolone | 2020 |
New onset weakness in the face and arm.
Topics: Adult; Arm; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Lupus Vasculitis, Central Nervous System; Methylprednisolone; Neuroimaging; Neuroprotective Agents; Paresis; Tomography, X-Ray Computed; Treatment Outcome | 2020 |
A case of chronic sarcoidosis presenting with lupus pernio.
Topics: Antirheumatic Agents; Biopsy; Chilblains; Diagnosis, Differential; Female; Humans; Hydroxychloroquine; Inflammation; Lung; Methylprednisolone; Middle Aged; Respiratory Function Tests; Sarcoidosis, Pulmonary; Skin; Tomography, X-Ray Computed; Treatment Outcome | 2020 |
Threatening drug-drug interaction in a kidney transplant patient with coronavirus disease 2019 (COVID-19).
Topics: Adult; Antiviral Agents; Betacoronavirus; C-Reactive Protein; Ciliopathies; Cobicistat; Common Cold; Coronavirus Infections; Cough; COVID-19; COVID-19 Drug Treatment; Cytochrome P-450 CYP3A Inhibitors; Darunavir; Deprescriptions; Drug Combinations; Drug Interactions; Enzyme Inhibitors; Fatigue; Female; Glucocorticoids; Graft Rejection; Humans; Hydroxychloroquine; Immunocompromised Host; Immunosuppressive Agents; Interleukin-10; Interleukin-1beta; Interleukin-6; Interleukin-8; Kidney Diseases, Cystic; Kidney Failure, Chronic; Kidney Transplantation; Leber Congenital Amaurosis; Lopinavir; Methylprednisolone; Optic Atrophies, Hereditary; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2; Severity of Illness Index; Tacrolimus | 2020 |
Coronavirus disease-2019 in cancer patients. A report of the first 25 cancer patients in a western country (Italy).
Topics: Age Factors; Aged; Aged, 80 and over; Antiviral Agents; Azithromycin; Betacoronavirus; Ceftriaxone; Cobicistat; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Darunavir; Drug Therapy, Combination; Female; HIV Protease Inhibitors; Humans; Hydroxychloroquine; Italy; Lopinavir; Male; Methylprednisolone; Middle Aged; Neoplasms; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2 | 2020 |
Steroid-Responsive Encephalitis in Coronavirus Disease 2019.
Topics: Akinetic Mutism; Antiviral Agents; beta 2-Microglobulin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Electroencephalography; Encephalitis; Glucocorticoids; Humans; Hydroxychloroquine; Interleukin-6; Interleukin-8; Lopinavir; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2; Treatment Outcome; Tumor Necrosis Factor-alpha | 2020 |
Evolution and resolution of brain involvement associated with SARS- CoV2 infection: A close Clinical - Paraclinical follow up study of a case.
Topics: Adult; Anti-Bacterial Agents; Anticonvulsants; Atazanavir Sulfate; Betacoronavirus; Brain; Consciousness Disorders; Coronavirus Infections; COVID-19; Diffusion Magnetic Resonance Imaging; Disease Progression; Encephalitis; Female; Glucocorticoids; HIV Protease Inhibitors; Humans; Hydroxychloroquine; Immunoglobulins, Intravenous; Immunologic Factors; Intensive Care Units; Levetiracetam; Lung; Magnetic Resonance Imaging; Methylprednisolone; Pandemics; Pneumonia, Viral; Pons; Respiration, Artificial; SARS-CoV-2; Seizures; Temporal Lobe; Thalamus; Tomography, X-Ray Computed | 2020 |
COVID-19 pneumonia in kidney transplant recipients: Focus on immunosuppression management.
Topics: Acute Kidney Injury; Adult; Aged; Azithromycin; Calcineurin Inhibitors; COVID-19; COVID-19 Nucleic Acid Testing; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Graft Rejection; Humans; Hydroxychloroquine; Immunocompromised Host; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; New York City; Prednisone; Renal Replacement Therapy; Respiration, Artificial; Retrospective Studies; RNA, Viral; SARS-CoV-2; Transplant Recipients; Treatment Outcome | 2020 |
Heart transplant recipient patient with COVID-19 treated with tocilizumab.
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Anticoagulants; Cardiomyopathy, Dilated; Cough; COVID-19; COVID-19 Drug Treatment; Diarrhea; Enoxaparin; Enzyme Inhibitors; Exanthema; Fever; Glucocorticoids; Heart Transplantation; Humans; Hydroxychloroquine; Hypoxia; Immunocompromised Host; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Nausea; Piperacillin, Tazobactam Drug Combination; Pulmonary Disease, Chronic Obstructive; Renal Insufficiency, Chronic; SARS-CoV-2; Tachypnea; Treatment Outcome | 2020 |
Red blood cell exchange to avoid intubating a COVID-19 positive patient with sickle cell disease?
Topics: Acute Chest Syndrome; Adult; Analgesics; Anemia, Sickle Cell; Antiviral Agents; Azithromycin; Betacoronavirus; Combined Modality Therapy; Contraindications, Procedure; Coronavirus Infections; COVID-19; Erythrocyte Transfusion; Humans; Hydroxychloroquine; Intubation, Intratracheal; Male; Methylprednisolone; Oxygen Inhalation Therapy; Pandemics; Pneumonia, Viral; Respiration, Artificial; Respiratory Insufficiency; SARS-CoV-2 | 2020 |
The use of IV vitamin C for patients with COVID-19: a case series.
Topics: Administration, Intravenous; Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antiviral Agents; Ascorbic Acid; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Feasibility Studies; Female; Ferritins; Fibrin Fibrinogen Degradation Products; Hospital Mortality; Humans; Hydroxychloroquine; Hypoxia; Intubation, Intratracheal; Male; Methylprednisolone; Middle Aged; Respiration, Artificial; Retrospective Studies; Severity of Illness Index; Vitamins | 2020 |
Lentiform fork sign in a patient with systemic lupus erythematosus.
Topics: Aged; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Magnetic Resonance Imaging; Methylprednisolone; Parkinsonian Disorders | 2021 |
A Patient with Cryoglobulinemic Membranoproliferative GN (MPGN) Who Survived COVID-19 Disease: Case Presentation and Current Data of COVID-19 Infection in Dialysis and Transplanted Patients in Greece.
Topics: Anti-Bacterial Agents; Azithromycin; Betacoronavirus; Ceftriaxone; Coronavirus Infections; COVID-19; Creatinine; Cryoglobulinemia; Cyclophosphamide; Enzyme Inhibitors; Glomerulonephritis, Membranoproliferative; Glucocorticoids; Greece; Humans; Hydroxychloroquine; Immunocompromised Host; Immunologic Factors; Kidney Failure, Chronic; Kidney Transplantation; Leukemia, Lymphocytic, Chronic, B-Cell; Lung; Male; Methylprednisolone; Middle Aged; Pandemics; Pneumonia, Viral; Renal Dialysis; Respiration, Artificial; Respiratory Insufficiency; Reverse Transcriptase Polymerase Chain Reaction; Rituximab; SARS-CoV-2; Tomography, X-Ray Computed | 2020 |
Tocilizumab and steroid treatment in patients with COVID-19 pneumonia.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antimalarials; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Darunavir; Female; Follow-Up Studies; HIV Protease Inhibitors; Humans; Hydroxychloroquine; Male; Methylprednisolone; Middle Aged; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2; Treatment Outcome | 2020 |
Fatal outcome of anti-MDA5 juvenile dermatomyositis in a paediatric COVID-19 patient: a case report.
Topics: Adenosine Monophosphate; Alanine; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antiviral Agents; Autoantibodies; Bronchoscopy; Child; COVID-19; COVID-19 Nucleic Acid Testing; Cyclophosphamide; Dermatomyositis; Disease Progression; Fatal Outcome; Female; Humans; Hydroxychloroquine; Immunocompromised Host; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Interferon-Induced Helicase, IFIH1; Lung; Lung Diseases, Interstitial; Lymphohistiocytosis, Hemophagocytic; Mediastinal Emphysema; Methylprednisolone; Piperidines; Pneumonia, Pneumocystis; Pneumothorax; Pyrimidines; Respiratory Insufficiency; Shock, Septic; Subcutaneous Emphysema; Tomography, X-Ray Computed; Trimethoprim, Sulfamethoxazole Drug Combination | 2021 |
Baricitinib improves respiratory function in patients treated with corticosteroids for SARS-CoV-2 pneumonia: an observational cohort study.
Topics: Aged; Antiviral Agents; Azetidines; Cohort Studies; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Drug Therapy, Combination; Endothelium, Vascular; Enzyme Inhibitors; Female; Fibrin Fibrinogen Degradation Products; Glucocorticoids; Humans; Hydroxychloroquine; Hypoxia; Immunoglobulins, Intravenous; Immunologic Factors; Interferon beta-1b; Janus Kinase Inhibitors; Lopinavir; Lung; Male; Methylprednisolone; Middle Aged; Oximetry; Oxygen Inhalation Therapy; Prospective Studies; Purines; Pyrazoles; Ritonavir; SARS-CoV-2; Severity of Illness Index; Sulfonamides | 2021 |
Continuous positive airway pressure in COVID-19 patients with moderate-to-severe respiratory failure.
Topics: Adult; Aged; Aged, 80 and over; Air Filters; Algorithms; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Comorbidity; Continuous Positive Airway Pressure; COVID-19; COVID-19 Drug Treatment; Diabetes Mellitus; Female; Glucocorticoids; Humans; Hydroxychloroquine; Hypertension; Hypoxia; Interleukin 1 Receptor Antagonist Protein; Intubation, Intratracheal; Lung; Male; Methylprednisolone; Middle Aged; Noninvasive Ventilation; Oxygen Inhalation Therapy; Partial Pressure; Pulmonary Disease, Chronic Obstructive; Respiratory Insufficiency; SARS-CoV-2; Severity of Illness Index; Sex Factors; Tomography, X-Ray Computed; Treatment Failure; Treatment Outcome | 2021 |
Acute aortic dissection in a patient with Williams syndrome infected by COVID-19.
Topics: Adolescent; Anti-Bacterial Agents; Antiviral Agents; Aortic Aneurysm; Aortic Dissection; Aortic Stenosis, Supravalvular; Aortitis; Azithromycin; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Enzyme Inhibitors; Fatal Outcome; Glucocorticoids; Humans; Hydroxychloroquine; Immunoglobulins, Intravenous; Immunologic Factors; Lopinavir; Male; Methylprednisolone; Oseltamivir; Recurrence; Ritonavir; SARS-CoV-2; Systemic Inflammatory Response Syndrome; Williams Syndrome | 2021 |
Pediatric catastrophic antiphospholipid syndrome patient evolving to systemic lupus erythematosus.
Topics: Adolescent; Antibodies, Antinuclear; Antiphospholipid Syndrome; Catastrophic Illness; Female; Heparin; Humans; Hydroxychloroquine; Immunoglobulins, Intravenous; Lupus Coagulation Inhibitor; Lupus Erythematosus, Systemic; Methylprednisolone; Peritonitis; Thrombosis; Treatment Outcome | 2021 |
Acute generalized exanthematous pustulosis and Stevens-Johnson syndrome overlap due to hydroxychloroquine: a case report.
Topics: Acute Generalized Exanthematous Pustulosis; Aged; Antimalarials; Biopsy; Coronavirus Infections; COVID-19; Female; Humans; Hydroxychloroquine; Immunoglobulins, Intravenous; Immunologic Factors; Methylprednisolone; Pandemics; Pneumonia, Viral; Sarcoidosis; Skin; Skin Diseases; Stevens-Johnson Syndrome; Treatment Outcome | 2020 |
Clinical features and outcomes from the Singapore Sjögren's syndrome study.
Topics: Adult; Arthralgia; Azathioprine; Female; Humans; Hydroxychloroquine; Keratoconjunctivitis Sicca; Male; Methotrexate; Methylprednisolone; Middle Aged; Peripheral Nervous System Diseases; Retrospective Studies; Singapore; Sjogren's Syndrome; Xerostomia | 2021 |
Azithromycin, a questionable treatment for COVID-19.
Topics: Azithromycin; COVID-19 Drug Treatment; Drug Combinations; Drug Therapy, Combination; Humans; Hydroxychloroquine; Lopinavir; Methylprednisolone; Ritonavir; SARS-CoV-2 | 2021 |
Myositis due to COVID-19.
Topics: Adult; Amides; Antiviral Agents; C-Reactive Protein; COVID-19; COVID-19 Nucleic Acid Testing; Creatine Kinase; Fibrin Fibrinogen Degradation Products; Glucocorticoids; Humans; Hydroxychloroquine; Lung; Lymphopenia; Magnetic Resonance Imaging; Male; Methylprednisolone; Muscle, Skeletal; Myositis; Pyrazines; SARS-CoV-2; Tomography, X-Ray Computed | 2021 |
Successful Management of COVID-19 Infection in 2 Early Post-Liver Transplant Recipients.
Topics: Adenosine Monophosphate; Aged; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Female; Humans; Hydroxychloroquine; Immunization, Passive; Immunosuppressive Agents; Liver Failure; Liver Transplantation; Methylprednisolone; Middle Aged; SARS-CoV-2 | 2021 |
Comparison of demographic and clinical characteristics of hospitalized COVID-19 patients with severe/critical illness in the first wave versus the second wave.
Topics: Aged; Amides; Antibodies, Monoclonal, Humanized; Azithromycin; C-Reactive Protein; Comorbidity; COVID-19; COVID-19 Drug Treatment; Critical Care; Drug Combinations; Enoxaparin; Female; Hospital Mortality; Hospitalization; Humans; Hydroxychloroquine; Interleukin 1 Receptor Antagonist Protein; Lopinavir; Male; Methylprednisolone; Middle Aged; Pyrazines; Retrospective Studies; Ritonavir; SARS-CoV-2; Severity of Illness Index; Treatment Outcome; Turkey | 2022 |
75-Year-Old Man With Fever and Malaise.
Topics: Acute Kidney Injury; Aged; Antirheumatic Agents; Diagnosis, Differential; Humans; Hydroxychloroquine; Immunologic Tests; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Methylprednisolone; Mycophenolic Acid; Pleural Effusion; Prognosis; Remission Induction; Renal Dialysis | 2021 |
Catastrophic Anti-Phospholipid Syndrome in Systemic Lupus Erythematosus: A Tsunami in the Ocean.
Topics: Adult; Antiphospholipid Syndrome; Cyclophosphamide; Female; Humans; Hydroxychloroquine; Immunoglobulins, Intravenous; Lupus Coagulation Inhibitor; Lupus Erythematosus, Systemic; Methylprednisolone; Middle Aged; Pregnancy; Thrombosis; Young Adult | 2022 |
Refractory Behçet's disease treated with low-dose interleukin-2: A case report.
Topics: Adult; Behcet Syndrome; Erythema Nodosum; Female; Humans; Hydroxychloroquine; Interleukin-2; Methylprednisolone; Oral Ulcer; Thalidomide | 2022 |